Bizily Scottinsider trades
In SEC Form 4 filings, Bizily Scott is listed as Chief Legal Officer of 4D Molecular Therapeutics, Inc. (FDMT). In the last 90 days, Bizily Scott sold $51.5K of 4D Molecular Therapeutics, Inc. (FDMT) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| FDMT4D Molecular Therapeutics, Inc. | Chief Legal Officer | 9 | Oct 20 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| FDMT4D Molecular Therapeutics, Inc. | Oct 16 | Oct 20 | M | 1,635 | $4.14 | $6,769 | 10,252 | Yes | Form 4 |
| FDMT4D Molecular Therapeutics, Inc. | Oct 16 | Oct 20 | S | 1,635 | $12.84 | Sale −$20,993 | 8,617 | Yes | Form 4 |
| FDMT4D Molecular Therapeutics, Inc. | Oct 16 | Oct 20 | M · derivative | 1,635 | $4.14 | $6,769 | 56,431 | Yes | Form 4 |
| FDMT4D Molecular Therapeutics, Inc. | Sep 16 | Sep 22 | M | 1,635 | $4.14 | $6,769 | 10,252 | Yes | Form 4 |
| FDMT4D Molecular Therapeutics, Inc. | Sep 16 | Sep 22 | S | 1,635 | $13.65 | Sale −$22,318 | 8,617 | Yes | Form 4 |
| FDMT4D Molecular Therapeutics, Inc. | Sep 16 | Sep 22 | M · derivative | 1,635 | $4.14 | $6,769 | 58,066 | Yes | Form 4 |
| FDMT4D Molecular Therapeutics, Inc. | Sep 1 | Sep 3 | M | 584 | $6.49 | $3,790 | 9,201 | Yes | Form 4 |
| FDMT4D Molecular Therapeutics, Inc. | Sep 1 | Sep 3 | S | 584 | $14.00 | Sale −$8,176 | 8,617 | Yes | Form 4 |
| FDMT4D Molecular Therapeutics, Inc. | Sep 1 | Sep 3 | M · derivative | 584 | $6.49 | $3,790 | 2,959 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.